Activated recombinant human coagulation factor VII therapy for intracranial hemorrhage in patients with hemophilia A or B with inhibitors. Results of the novoseven emergency-use program - Arkin, S; Cooper, HA; Hutter, JJ (Haemostasis, 1998)